Showing results (71-80 of 168) with videos related to
Sort By:
Pageof 17
British Journal of Cancer|July 29, 2016
FOLFIRINOX for advanced pancreatic cancer: the Princess Margaret Cancer Centre experienceMuralidharan K Chllamma, Natalie Cook, Neesha C Dhani, et al.Practical Radiation Oncology|April 27, 2017
Dosimetric analysis of liver toxicity after liver metastasis stereotactic body radiation therapyAisling Barry, Andrew McPartlin, Patricia Lindsay, et al.The Oncologist|March 6, 2019
Referrals to a Phase I Clinic and Trial Enrollment in the Molecular Screening EraTira Tan, Michael Rheaume, Lisa Wang, et al.International Journal of Radiation Oncology, Biology, Physics|March 24, 2017
Predictors of Liver Toxicity Following Stereotactic Body Radiation Therapy for Hepatocellular CarcinomaMichael Velec, Carol R Haddad, Tim Craig, et al.Cancer Chemotherapy and Pharmacology|November 10, 2019
Characterization and outcomes of patients enrolled to multiple phase I cancer trialsNathan Kuehne, Lina Chen, Kate McDonald, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2012
Phase II clinical and pharmacokinetic study of aflibercept in patients with previously treated metastatic colorectal cancerPatricia A Tang, Steven J Cohen, Christian Kollmannsberger, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 21, 2010
Evaluation of pandemic H1N1 (2009) influenza vaccine in adults with solid tumor and hematological malignancies on active systemic treatmentHelen J Mackay, Jacob McGee, Diego Villa, et al.Gynecologic Oncology|June 3, 2014
A phase II trial of sunitinib in women with metastatic or recurrent endometrial carcinoma: a study of the Princess Margaret, Chicago and California ConsortiaVincent Castonguay, Stephanie Lheureux, Stephen Welch, et al.Investigational New Drugs|May 11, 2010
A dose-escalation phase I trial of nimotuzumab, an antibody against the epidermal growth factor receptor, in patients with advanced solid malignanciesBenoit You, Anthony Brade, Joao M Magalhaes, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 19, 2013
Dosimetric and clinical impact of 3D vs. 2D planning in palliative radiotherapy for bone metastasesKathy Pope, David Fitzpatrick, Andrew Potter, et al.Pageof 17